P&G; began buying shares of Richardson-Vicks.
Through a newly formed subsidiary, RVI Acquisition, Procter & Gamble took the first step in its planned $1.2-billion acquisition of the maker of Vicks cold remedies and other products by beginning a $69-per-share tender offer. The tender offer expires Nov. 1, with P&G; retaining withdrawal rights until midnight Oct. 25.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
